A 14-month-old boy presents to the pediatric clinic with a 24-hour history of fever (38.5°C), ear pulling, and inconsolability. On otoscopic examination, the tympanic membrane is erythematous and bulging. The finding marked **D** in the diagram (pneumatic otoscopy showing reduced mobility) is documented. Which of the following is the MOST appropriate next step in management?

Explanation

## Why high-dose amoxicillin 80–90 mg/kg/day is correct The reduced tympanic membrane mobility documented by pneumatic otoscopy (marked **D**) confirms middle ear effusion, which combined with acute onset (< 48 hr), fever, and signs of inflammation (bulging, erythema, otalgia) satisfies ALL three AAP 2013 diagnostic criteria for acute otitis media (AOM). The patient is 14 months old (within the peak risk age of 6–24 months) with SEVERE disease (fever 38.5°C, duration < 48 hr, but significant otalgia/inconsolability). Per AAP guidelines, ALL children < 2 years with AOM require antibiotics; high-dose amoxicillin (80–90 mg/kg/day in 2 divided doses × 10 days) is the first-line agent, ensuring coverage of penicillin-resistant *Streptococcus pneumoniae*, *Haemophilus influenzae* non-typable, and *Moraxella catarrhalis*. Pneumatic otoscopy showing reduced mobility is the KEY CONFIRMATORY TEST that distinguishes AOM from viral upper respiratory infection or external otitis and is ESSENTIAL for diagnosis (Nelson 21e Ch 658; AAP 2013). ## Why each distractor is wrong - **"Wait-and-see" prescription**: This observation strategy is appropriate ONLY for non-severe, unilateral AOM in children ≥ 6 months; this patient is 14 months old with fever and significant symptoms, and the reduced TM mobility on pneumatic otoscopy confirms middle ear effusion—antibiotic therapy is indicated. - **Observation alone without antibiotics**: Observation without any antibiotic prescription is not recommended for any child < 2 years with confirmed AOM; it risks progression to complications (mastoiditis, intracranial spread) and delays symptom relief. - **Single IM ceftriaxone dose**: Ceftriaxone is reserved for penicillin-allergic patients or those with amoxicillin failure/recent antibiotic exposure; it is not first-line and a single dose is inadequate (requires 3 days of IM dosing if used). **High-Yield:** Pneumatic otoscopy demonstrating reduced TM mobility is the GOLD STANDARD confirmatory test for middle ear effusion in AOM; combined with acute onset and inflammation signs, it mandates antibiotic therapy in children < 2 years. [cite: Nelson Textbook of Pediatrics 21e, Chapter 658; American Academy of Pediatrics Clinical Practice Guideline for Acute Otitis Media, 2013]